Lonza
One of the leading global suppliers of active ingredients, chemical intermediates and biotechnology solutions to the pharmaceutical and agrochemical industries.
Enterprise value
$40.6b
Share price
CHF565.00 LONN.SW
Company register number
Recent deals
Get premium to view all results
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | investor | €0.0 | round |
| N/A | €0.0 | round | |
| investor investor | €0.0 Valuation: €0.0 | round | |
| N/A | €0.0 | round | |
| investor | €0.0 | round | |
* | N/A | €1.0b | Post IPO Debt |
| Total Funding | 000k | ||
| CHF | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|
| Revenues | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % growth | - | - | 266 % | 8 % | (2 %) | 27 % | 12 % |
| EBITDA | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % EBITDA margin | - | 77 % | 31 % | 14 % | 18 % | - | - |
| Profit | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % profit margin | - | 173 % | 20 % | 10 % | 10 % | - | - |
| EV | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| EV / revenue | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| EV / EBITDA | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| R&D budget | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| R&D % of revenue | - | 5 % | 2 % | 2 % | 2 % | - | - |
Source: Company filings or news article, Equity research estimates
Related Content
Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads
Tech stack
Tech stackLearn more about the technologies and tools that this company uses.
Investments analysisEdit
Investments by Lonza
Edit
ACQUISITION by Lonza Jun 2023
ACQUISITION by Lonza May 2008
ACQUISITION by Lonza Nov 2009
ACQUISITION by Lonza May 2017
ACQUISITION by Lonza Aug 2016
ACQUISITION by Lonza Jun 2016
ACQUISITION by Lonza Dec 2016
ACQUISITION by Bioceros Sep 2005